Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

Impact of Tissue Plasminogen Activator on the Neurovascular Unit: From Clinical Data to Experimental Evidence - Denis Vivien, Maxime Gauberti, Axel Montagne, Gilles Defer, Emmanuel Touzé, 2011

Tissue Plasminogen Activator for Acute Ischemic Stroke (Alteplase, Activase®)

tPA (Tissue Plasminogen Activator) for Stroke

Frontiers Factors associated with functional disability in patients with acute stroke excluded from alteplase administration due to minor non-disabling neurological deficits

Acute Ischemic Stroke (AIS) Market Size and Forecast to 2030

Thrombolytics for acute ischemic stroke - NNT evidence review - First10EM

JCM, Free Full-Text

Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers

Hyperacute Management of Ischemic Strokes: JACC Focus Seminar

PDF) Tissue plasminogen activator for acute ischemic stroke

EmpireGene

Intravenous recombinant tissue plasminogen activator for acute ischemi